James Bearden to Prostatic Neoplasms, Castration-Resistant
This is a "connection" page, showing publications James Bearden has written about Prostatic Neoplasms, Castration-Resistant.
Connection Strength
0.194
-
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer. Cancer. 2021 08 15; 127(16):2954-2965.
Score: 0.194